AARON BRADLEY CATMULL

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family RUPERT, ID NPI 1891101937

General Payments — all program years on this page

$849.67

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 40
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $543.87 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $543.8721

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $68.124
2022 $66.575
2023 $171.1110
2024 $543.8721

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086751781 Novartis Pharmaceuticals Corporation $17.72 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086751791 Novartis Pharmaceuticals Corporation $20.94 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100490209 Novo Nordisk Inc $13.41 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104654055 AstraZeneca Pharmaceuticals LP $148.06 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105638604 AstraZeneca Pharmaceuticals LP $16.48 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106894783 ABBVIE INC. $31.86 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106894785 ABBVIE INC. $20.03 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106894787 ABBVIE INC. $17.45 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106894789 ABBVIE INC. $17.98 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106894791 ABBVIE INC. $22.56 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106894793 ABBVIE INC. $18.98 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114430902 Exact Sciences Corporation $14.48 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114430907 Exact Sciences Corporation $15.72 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114430912 Exact Sciences Corporation $16.27 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116306601 GlaxoSmithKline, LLC. $14.94 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118216034 Boehringer Ingelheim Pharmaceuticals, Inc. $17.32 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118216038 Boehringer Ingelheim Pharmaceuticals, Inc. $17.75 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118216042 Boehringer Ingelheim Pharmaceuticals, Inc. $20.00 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135487306 Lilly USA, LLC $15.13 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139489082 Astellas Pharma US Inc $32.95 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139537688 Astellas Pharma US Inc $33.84 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.